Melanoma, NKI/C3
-
Catalog numberME100
-
PricePlease ask
-
Size1 mL
-
-
CloneNKI/C3
-
Species ReactivityHuman
-
Product TypesPrimary Antibodies
-
Positive ControlMelanoma
-
ImmunogenProtein extract of human melanoma cell line
-
Working Concentration(liquid conc.) 1:10 - 1:20
-
ConcentrationNA
-
Incubation Time60 min at RT
-
ApplicationIHC(P)
-
Storage2-8°C
-
UniProtNA
-
Gene target
-
Short nameMelanoma, NKI/C3
-
HostMouse
-
IsotypeIgG1
-
Alternative nameMelanoma, NKI/complement component 3
-
Alternative to gene targetcomplement component 3, AHUS5 and ARMD9 and ASP and C3a and C3b and CPAMD1 and HEL-S-62p, C3 and IDBG-21798 and ENSG00000125730 and 718, C5L2 anaphylatoxin chemotactic receptor binding, Extracellular, C3 and IDBG-193788 and ENSMUSG00000024164 and 102642251,12266, BT.19562 and IDBG-643930 and ENSBTAG00000017280 and 280677
-
MeSH Data
-
Name
-
ConceptScope note: Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
-
Tree numbers
- C04.588.531.500
- C04.619.590
- E05.598.500.496.843
-
Qualifiersdiagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, secondary, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, chemistry, psychology, urine, virology, history, blood supply, classification, economics, embryology, genetics, nursing, radiotherapy, prevention & control, pathology, ultrastructure, metabolism, complications, surgery